A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002223
- Lead Sponsor
- Abbott
- Brief Summary
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
Tower Infectious Diseases
🇺🇸Los Angeles, California, United States
Urgent Care Ctr / North Broward Hosp District
🇺🇸Fort Lauderdale, Florida, United States
Stephen Hauptman
🇺🇸Philadelphia, Pennsylvania, United States
Goodgame Med Ctr / Central Florida Research Initiati
🇺🇸Maitland, Florida, United States
Mount Sinai Med Ctr
🇺🇸New York, New York, United States
AIDS Healthcare Foundation
🇺🇸Los Angeles, California, United States